CDKN2A and pancreatic adenocarcinoma: In addition, regardless of mutation quantity and frequency, we observed obvious mutations such as TP53, CDKN2A, TTN, CKDN2A-DT, LRP1B, etc., which might be of vital importance to the tumorigenesis and development of PAAD.